Hikma Pharmaceutical reported 127.39B in Debt for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
AstraZeneca AZN:LN 2425311.81M 57309.55M
Bayer BAYN:GR € 44634M 2087M
Fresenius FRE:GR € 28368M 1157M
Galapagos GLPG:NA € 24.05M 1.3M
Genmab GEN:DC DK 634M 218M
GlaxoSmithKline GSK:LN 2211100M 1121700M
Hikma Pharmaceutical HIK:LN 127.39B 64.86B
Lonza Group LONN:SW 2.4B 0
Merck MRK:GR € 11803M 1172M
Orion ORNBV:FH € 253.6M 121.7M
Recordati REC:IM € 1827.9M 157.02M